Aricept
Active ingredient: Donepezil
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Its active ingredient, donepezil, supports acetylcholine signalling in the brain and may help preserve thinking, memory, and independence for some adults. Aricept is prescribed for symptomatic treatment of Alzheimer’s disease and belongs to the acetylcholinesterase inhibitor group.
Product information
Aricept is used to manage cognitive and daily-function symptoms associated with Alzheimer’s disease.
How it affects the body
Donepezil is an acetylcholinesterase inhibitor. It reduces the activity of acetylcholinesterase, the enzyme responsible for breaking down acetylcholine, thereby maintaining more acetylcholine between nerve cells.
Ingredients
Aricept contains donepezil, an acetylcholinesterase inhibitor used in neurology for symptomatic treatment of Alzheimer’s disease. Donepezil slows the breakdown of acetylcholine, a chemical messenger involved in memory, attention, and thinking. By maintaining more acetylcholine between nerve cells, Aricept may support cognitive and functional abilities in some patients. [1]
Aricept does not remove the underlying cause of Alzheimer’s disease. It does not repair established brain damage, and the response differs between individuals. Treatment decisions depend on the diagnosis, daily function, other illnesses, current medicines, and how the person tolerates treatment.
Donepezil as the Active Ingredient
Donepezil is the active ingredient in Aricept. The term acetylcholinesterase inhibitor describes a medicine that reduces the activity of acetylcholinesterase, the enzyme responsible for breaking down acetylcholine.
The result is symptom support rather than a cure. A person may show better attention, more consistent daily routines, or slower loss of abilities, while another person may show little visible change.
Alzheimer’s Disease Symptom Support
Aricept is prescribed after assessment of memory problems and the likely cause of cognitive decline. The diagnosis matters because not every cause of memory loss responds to donepezil.
Caregivers can provide useful observations. Changes in dressing, eating, conversations, medication routines, sleep, and household safety may reveal treatment response more clearly than a single memory test.
Dosage and administration
Aricept is taken by mouth once daily at the prescribed dose. Take it at a consistent time and swallow the tablet according to the product directions. Donepezil remains in the body for a long period, so extra tablets can increase adverse effects rather than safely correcting a missed dose.
- Take one prescribed dose each day.
- Link the dose with a stable routine, such as brushing the teeth or preparing for sleep.
- Do not double the next dose after forgetting one.
- If several doses are missed, obtain restart instructions from the prescribing clinician or a pharmacist.
- Do not alter the dose because memory seems better or worse on one day.
- Report repeated vomiting, fainting, black stools, or marked dizziness promptly.
Food may reduce stomach discomfort for some people, but the product directions and prescribed routine take priority. Taking the tablet at different times each day can make adherence harder, especially when a caregiver manages medicines.
When not to use it
Clinical review is needed when a person has a slow pulse, fainting episodes, conduction problems, seizure history, asthma or chronic obstructive pulmonary disease, peptic ulcer disease, urinary obstruction, or a history of falls.
Donepezil can increase vagal activity and may worsen bradycardia in susceptible people. Gastrointestinal bleeding risk also matters, especially in people with a history of ulcers or those taking anti-inflammatory pain medicines. [2]
When this is not for you
NOT for you if the diagnosis is uncertain, fainting or slow pulse is uncontrolled, or adverse effects outweigh meaningful functional benefit.
Possible side effects
Donepezil can cause gastrointestinal, neurological, muscular, and cardiovascular adverse effects. The most frequently reported problems include nausea, diarrhoea, vomiting, reduced appetite, muscle cramps, dizziness, headache, and insomnia. These effects may be more noticeable after treatment starts or after a dose increase.
Weight loss deserves attention in older adults. A gradual reduction in appetite may be missed when nobody records meals or checks weight.
Common Tolerability Effects
Mild nausea or loose stools may settle as the body adjusts. Persistent symptoms can cause dehydration, weakness, falls, or poor nutrition, so they should not be ignored.
Sleep changes can include vivid dreams or difficulty sleeping. Headache and muscle cramps may also affect daily comfort. The prescriber may review timing, other medicines, hydration, and the continued need for treatment.
Urgent Symptoms and Clinical Review
Seek urgent medical help for:
- Fainting, collapse, or a very slow heartbeat
- New chest discomfort or severe weakness
- Black, tarry stools or vomiting blood
- Seizures
- Breathing difficulty or swelling of the face, lips, tongue, or throat
- Widespread blistering, peeling skin, or painful skin changes
- Severe confusion accompanied by a fall or injury
Therapeutic indications
Aricept is used to manage cognitive and daily-function symptoms associated with Alzheimer’s disease.
Aricept is prescribed after assessment of memory problems and the likely cause of cognitive decline. The diagnosis matters because not every cause of memory loss responds to donepezil.
Comparison
Donepezil belongs to the acetylcholinesterase inhibitor group. Other medicines in the same broad group include rivastigmine and galantamine. Memantine belongs to a different pharmacological group and affects glutamate signalling rather than acetylcholine breakdown.
| Medicine category | Administration options | Selection considerations |
|---|---|---|
| Donepezil | Oral tablets and other oral formulations | Once-daily routine; nausea, sleep effects, pulse, and falls require review |
| Rivastigmine | Oral treatment or transdermal patch | Patch delivery may suit some adherence patterns; skin and gastrointestinal effects require monitoring |
| Galantamine | Oral treatment | Gastrointestinal effects, adherence, kidney function, and other medicines influence selection |
No option is universally best. Diagnosis, kidney and liver function, heart rate, swallowing ability, adherence, previous response, and caregiver support all influence selection. Switching or combining cognitive medicines requires a clinician’s plan.
Memantine may be considered in selected stages or clinical situations, but it is not a substitute for an individual assessment. Treatment changes should be supervised by the clinician managing dementia care.
Common mistakes
- Doubling a missed dose: Extra tablets can increase nausea, dizziness, cramps, vomiting, or slow heartbeat.
- Changing strength without advice: Moving from a lower to a higher tablet strength can produce avoidable adverse effects.
- Stopping after a short period: Donepezil may require time before benefit can be judged, and stopping decisions should be supervised.
- Hiding the medicine from caregivers: Concealed doses make missed doses and accidental repeat doses more likely.
- Ignoring appetite loss: Weight loss can become clinically significant before it looks dramatic.
- Assuming no instant memory improvement means failure: Treatment may support daily function or slow decline without producing a striking memory change.
- Continuing after repeated falls: New falls may signal dizziness, low pulse, dehydration, or another medicine problem.
- Taking extra tablets after an interruption: Several missed doses may require specific restart advice.
A dose interruption can be more complicated than a single forgotten tablet. The correct restart plan depends on how long treatment was interrupted and the person’s health status.
What doctors say
In clinical practice, doctors assess function and safety, not memory scores alone. A treatment that helps someone continue dressing independently or follow a familiar routine may provide meaningful benefit even when formal testing changes little.
Clinicians also look for trade-offs. Better attention is useful, but repeated diarrhoea, weight loss, fainting, or insomnia may outweigh a modest cognitive benefit.
The FDA product information and dementia guidance used by European and international services support individual review of response, adverse effects, adherence, and ongoing goals rather than automatic dose escalation. [3]
Common questions
What happens if Aricept is stopped, and does it need tapering?
Stopping Aricept can remove its symptom-supporting effect, and cognitive or functional difficulties may become more noticeable. The FDA product information from 2023 describes donepezil as a long-acting treatment, so a supervised plan is preferable to abrupt self-directed changes. Tapering is not automatically required for every person, but the prescriber should decide whether to stop, reduce, or restart treatment. After several missed doses, ask the prescribing team for a specific restart plan rather than taking extra tablets. The reason for stopping should be recorded for later review.
How soon can the effect of Aricept become noticeable?
Some people notice changes in attention, routine, or daily function during the first treatment period, while others show little visible improvement. The EMA product information available in 2022 describes treatment response as individual and supports review of cognitive and functional effects rather than relying on a fixed promise. Caregiver observations may reveal gradual benefit before the patient notices it. A lack of immediate change does not by itself prove that treatment has failed.
Can Aricept tablets be split, crushed, or chewed?
Tablet handling depends on the specific formulation, so Aricept should be swallowed and handled according to its approved product instructions. WHO medication-safety principles published in 2023 caution against altering oral dosage forms without confirming that the formulation allows it. Crushing or chewing can create swallowing problems, unpleasant taste, or an unintended change in how the dose is delivered. Do not substitute two tablets for one prescribed tablet without a treatment plan.
Can a person drive, concentrate, or operate machinery while taking Aricept?
Aricept may cause dizziness, faintness, fatigue, muscle cramps, or sleep disturbance, which can impair driving and machinery work. The UAE Ministry of Health and Prevention, MOHAP, uses medication-safety principles that place responsibility on the treating clinician to assess individual fitness for such activities in 2024. Avoid driving or hazardous work until the effect of treatment is known and balance, alertness, and vision remain reliable. Any fainting episode requires prompt clinical assessment before resuming these activities.
What is the best time of day to take Aricept?
Aricept is taken once daily at a consistent time selected with the prescribing clinician. The FDA prescribing information from 2023 permits routine-based administration, while sleep disturbance or vivid dreams may make timing review useful. An evening dose may suit one person but worsen insomnia in another. Keep the schedule stable and report sleep problems instead of changing the timing repeatedly.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Sources
- U.S. Food and Drug Administration (2023). ARICEPT (donepezil hydrochloride) Tablets: Prescribing Information.
- U.S. Food and Drug Administration (2023). ARICEPT (donepezil hydrochloride) Tablets: Warnings and Precautions.
- National Institute for Health and Care Excellence (2022). Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers (NG97).